Find your next paid study

Fred Hutchinson Cancer CenterNCT03128034

~$150 – $3,000

Actual pay is set by the research site.

AgingPreventive CareMultimorbidity+1 more

Supporting Practices In Respecting Elders Phase 2

This study consists of three aims focused on examining the feasibility of adding the Geriatric Resources and Assessment for the Care of Elders (GRACE) model to…

Massachusetts General HospitalNCT07166861

Actual pay is set by the research site.

Head Neck CancerSquamous Cell Cancer of Head and Neck (SCCHN)Cancer Pain

Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy for Pain Palliation in Head, Neck, & Brachial Cancer

This phase 1 multi-site study investigates the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, …

University of VirginiaNCT07405645

Actual pay is set by the research site.

Elevated Blood PressureHypertension

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

The study will be a multi-center, randomized clinical trial to evaluate the safety and efficacy of using the Zona Plus handgrip therapy device compared to the …

Zona Health, IncNCT06843577

~$10 – $1,050

Actual pay is set by the research site.

Phase 2

Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery

The goal of this prospective pragmatic randomized clinical trial is to determine if preoperative administration of tranexamic acid (TXA) reduces bleeding durin…

BleedingColorectal DisordersThromboembolism+1 more

Hypoxic Ischemic Encephalopathy

~$75 – $3,000

Actual pay is set by the research site.

Kristen BanNCT06657924

Phase 1

Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia

Hypoxic-Ischemic Encephalopathy (HIE) occurs in 20 per 1000 births. Only 47% of neonates treated with the state of the art therapy (induced systemic hypothermi…

University of FloridaNCT02621944

~$150 – $3,000

Actual pay is set by the research site.

Short-Course Antifungal Therapy vs Standard of Care (14 Day Therapy) for Uncomplicated Candidemia (SCAT)

The goal of this clinical trial is to assess whether a seven-day course of standard of care (echinocandin) antifungal therapy is non-inferior to a 14-day cours…

Candidemia

Augusta UniversityNCT06907992

Actual pay is set by the research site.

Pediatric Cardiomyopathy Mutation Analysis

The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of…

CardiomyopathiesDilated CardiomyopathyHypertrophic Cardiomyopathy+3 more

Indiana UniversityNCT02432092

Actual pay is set by the research site.

Observational Prospective Multicenter Validation Study Investigating the Possibility of Replacing Cystoscopies With High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer (UROSCOUT-1)

Urothelial cancers of the bladder and upper urinary tract account for over 200,000 deaths and 600,000 diagnoses annually worldwide. The most common presenting …

Urothelial Carcinoma

Tampere University HospitalNCT06310759

Actual pay is set by the research site.

Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease

The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.

Endocrine Disease

M.D. Anderson Cancer CenterNCT03050762

Actual pay is set by the research site.

Pulmonary Arterial HypertensionPulmonary HypertensionRight Heart Dysfunction

An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System

This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients …

Phase 1Recurrent MelanomaRefractory Melanoma

~$10 – $1,050

Actual pay is set by the research site.

Aria CV, IncNCT04555161

Phase 1

Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)

To find the highest tolerable dose and recommended dose of PRAME-TCR-NK cells that can be given to participants with recurrent and/or refractory melanoma. The …